Mono Pharmacare Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	1,475	1,683	1,223	330.87	369.83	282.66
Other Revenue	0.89	0.89	0.25	0.57	1.1	1.12
Revenue	1,476	1,684	1,224	331.44	370.93	283.78
Revenue Growth (YoY)	3.14%	37.65%	269.19%	-10.65%	30.71%	142.81%
Cost of Revenue	1,348	1,524	1,107	292.42	347.3	265.87
Gross Profit	127.7	160.72	116.75	39.02	23.63	17.91
Selling, General & Admin	49.37	45.96	40.66	10.34	7.44	7.19
Other Operating Expenses	29.95	36.73	12.11	5.7	2.28	1.13
Operating Expenses	80.54	83.97	53.91	16.55	10.8	9.61
Operating Income	47.16	76.76	62.83	22.48	12.84	8.31
Interest Expense	-35.96	-35.53	-28.47	-8.46	-6.55	-6.45
Interest & Investment Income	8.13	8.13	0.26	0.03	0.09	-
Other Non Operating Income (Expenses)	-5.01	-4.72	-2.36	-0.86	-0.87	-0.17
Pretax Income	14.32	44.63	32.26	13.18	5.51	1.69
Income Tax Expense	5.89	13.57	7.67	3.73	2	0.74
Earnings From Continuing Operations	8.43	31.06	24.59	9.45	3.51	0.95
Minority Interest in Earnings	-0.1	-0.16	-0.17	-0.02	-	-
Net Income	8.33	30.9	24.42	9.44	3.51	0.95
Net Income to Common	8.33	30.9	24.42	9.44	3.51	0.95
Net Income Growth	-70.96%	26.52%	158.84%	168.91%	268.98%	377.89%
Shares Outstanding (Basic)	19	18	15	6	5	5
Shares Outstanding (Diluted)	19	18	15	6	5	5
Shares Change (YoY)	7.91%	15.09%	171.01%	15.18%	-	-
EPS (Basic)	0.43	1.75	1.59	1.67	0.71	0.19
EPS (Diluted)	0.43	1.75	1.59	1.67	0.71	0.19
EPS Growth	-73.09%	10.00%	-4.55%	134.45%	274.94%	400.00%
Free Cash Flow	5.87	-45.29	-89.47	-401.73	2.26	-8.47
Free Cash Flow Per Share	0.31	-2.56	-5.83	-70.92	0.46	-1.72
Gross Margin	8.65%	9.54%	9.54%	11.77%	6.37%	6.31%
Operating Margin	3.20%	4.56%	5.13%	6.78%	3.46%	2.93%
Profit Margin	0.56%	1.84%	2.00%	2.85%	0.95%	0.34%
Free Cash Flow Margin	0.40%	-2.69%	-7.31%	-121.21%	0.61%	-2.99%
EBITDA	48.39	78.04	63.98	22.98	13.92	9.59
EBITDA Margin	3.28%	4.63%	5.23%	6.93%	3.75%	3.38%
D&A For EBITDA	1.22	1.29	1.15	0.51	1.08	1.28
EBIT	47.16	76.76	62.83	22.48	12.84	8.31
EBIT Margin	3.20%	4.56%	5.13%	6.78%	3.46%	2.93%
Effective Tax Rate	41.14%	30.41%	23.78%	28.27%	36.30%	43.76%
Revenue as Reported	1,484	1,693	1,224	331.48	371.03	283.78
Advertising Expenses	-	6.49	4.31	1.21	0.32	1.24

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.